We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

126 hedge funds and large institutions have $90.6M invested in Bionano Genomics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more call options, than puts

Call options by funds: $1.6M | Put options by funds: $749K

17% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 35

0% less ownership

Funds ownership: 0.05% → 0.04% (-0%)

12% less funds holding

Funds holding: 143 → 126 (-17)

48% less capital invested

Capital invested by funds: $176M → $90.6M (-$84.9M)

65% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 26

Holders
126
Holders Change
-17
Holders Change %
-11.89%
% of All Funds
2.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
41
Reduced
35
Closed
26
Calls
$1.6M
Puts
$749K
Net Calls
+$854K
Net Calls Change
-$1.57M

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$1.2M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$607K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$513K
4
ACS
Archford Capital Strategies
Illinois
+$455K
5
State Street
State Street
Massachusetts
+$394K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.1M
2
Millennium Management
Millennium Management
New York
-$1.71M
3
Goldman Sachs
Goldman Sachs
New York
-$632K
4
Morgan Stanley
Morgan Stanley
New York
-$387K
5
Group One Trading
Group One Trading
Illinois
-$299K
Name Holding Trade Value Shares
Change 		Change in
Stake
Canada Pension Plan Investment Board
151
Canada Pension Plan Investment Board
Ontario, Canada
– -$14.6K -17 Closed
KAM
152
Knightsbridge Asset Management
California
– -$15K -17 Closed
PCM
153
Prelude Capital Management
New York
– -$14.6K -17 Closed
Rockefeller Capital Management
154
Rockefeller Capital Management
New York
– -$8K -10 Closed
Belvedere Trading
155
Belvedere Trading
Illinois
– -$1.78K -2 Closed
CA
156
Clearstead Advisors
Ohio
– -$730 -1 Closed
GEA
157
Glen Eagle Advisors
New Jersey
– -$1.22K -1 Closed
GRP
158
Global Retirement Partners
California
– -$584 -1 Closed
KIA
159
Kraematon Investment Advisors
Massachusetts
– -$730 -1 Closed
MCC
160
Money Concepts Capital
Florida
– -$1.28K -1 Closed
QT
161
Quantbot Technologies
New York
– -$1.03K -1 Closed
AWM
162
Accurate Wealth Management
Florida
– -$363 – –
EWA
163
EverSource Wealth Advisors
Alabama
– -$146 – –
Federated Hermes
164
Federated Hermes
Pennsylvania
– -$4 – –
3 4 5 6
7

BNGO Hedge Fund Activity: Q1 2023 in Review

126 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2023, worth a combined $90.6M — down 48% from $176M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of BNGO and 9 opened new positions — a net loss of 17 holders — while 35 trimmed existing stakes and 41 added.

The largest buyer was Nuveen, adding an estimated $1.2M. The largest seller was Citadel Advisors, cutting an estimated $2.1M.

  • 126 institutional investors held Bionano Genomics (BNGO) as of Q1 2023, down from 143 in Q4 2022.
  • Funds reported $90.6M of Bionano Genomics stock for Q1 2023, down 48% quarter-over-quarter.
  • 9 funds opened new Bionano Genomics positions in Q1 2023 and 26 closed out, a net change of -17 holders.
  • The largest Bionano Genomics buyer in Q1 2023 was Nuveen, an estimated $1.2M added.
  • The largest Bionano Genomics seller in Q1 2023 was Citadel Advisors, an estimated $2.1M sold.

Based on aggregated 13F filings for Q1 2023.